Amantadine, COVID-19 and Parkinsonism
نویسندگان
چکیده
منابع مشابه
Interactions of L-dopa and amantadine in patients with Parkinsonism.
Twenty-seven patients with Parkinson's disease participated in a double-blind crossover trial of L-dopa and amantadine. Each drug was given for six weeks, and six weeks were allowed to elapse between the two periods of treatment. Marked improvement occurred in patients given L-dopa first, whereas no clinical effect was observed in those patients treated first with amantadine. L-dopa was less be...
متن کاملParkinsonism-hyperpyrexia syndrome due to abrupt withdrawal of amantadine.
To the Editor—We read with interest “An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome” by Man.1 The report was of an 84-year-old man who developed parkinsonismhyperpyrexia syndrome (PHS) due to abrupt withdrawal of levodopa. We encountered another patient in May 2009 who developed PHS due to withdrawal of amantad...
متن کاملCOVID-19 and dermatologists
Since the beginning of COVID-19 pandemic on December 2019, challenges on economic, political, social, hygiene- therapeutic and life style have emerged in many countries. Many researches are investigating on virus characteristics and its behavior and also preventive and therapeutic measures. Despite the virus not being dermatotropic, several skin manifestations have been observed. In this review...
متن کاملCOVID-19 and hair (8)
The COVID-19 pandemic is still present and we are directly or indirectly affected by it. The skin is one of the organs that has some manifestations not only during the course of the disease, but also long after recovery and also after vaccination. Hair is one of the parts that, like the skin, may show disorders during and after recovery of the infection and also after vaccination. In this issue...
متن کاملVitamin C and COVID-19
Corona disease has killed at least 5 million people globally since it started in Wuhan, China in December 2019 (World Health Organization, 2021). The disease is caused by SARS-COVID-19, and is transmitted from person to person by respiratory droplets (Baladia et al., 2020, Ejaz et al., 2020). Although the early symptoms of COVID-19 include fever, weariness, headache, sore throat, cough, d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Medical Research
سال: 2020
ISSN: 0188-4409
DOI: 10.1016/j.arcmed.2020.07.001